Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation
about
LRRK2 phosphorylates novel tau epitopes and promotes tauopathyThe involvement of microRNAs in neurodegenerative diseasesGSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synucleinCombined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model.Bioactive marine drugs and marine biomaterials for brain diseasesTau phosphorylation at serine 396 residue is required for hippocampal LTDPINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis.MicroRNAs and the Regulation of Tau MetabolismSpecific serine-proline phosphorylation and glycogen synthase kinase 3β-directed subcellular targeting of stathmin 3/Sclip in neurons.Prostate-derived sterile 20-like kinases (PSKs/TAOKs) phosphorylate tau protein and are activated in tangle-bearing neurons in Alzheimer disease.Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase.Phosphopeptide enrichment with TiO2-modified membranes and investigation of tau protein phosphorylation.Inhibition of glycogen synthase kinase-3β prevents sympathetic hyperinnervation in infarcted rats.Early glycogen synthase kinase-3β and protein phosphatase 2A independent tau dephosphorylation during global brain ischaemia and reperfusion following cardiac arrest and the role of the adenosine monophosphate kinase pathwayHigh glucose upregulates BACE1-mediated Aβ production through ROS-dependent HIF-1α and LXRα/ABCA1-regulated lipid raft reorganization in SK-N-MC cells.Interaction between pathogenic proteins in neurodegenerative disorders.Decoding the non-coding RNAs in Alzheimer's disease.Tau-induced neurodegeneration: mechanisms and targets.Potential application of lithium in Parkinson's and other neurodegenerative diseases.Amyloid β-Exposed Human Astrocytes Overproduce Phospho-Tau and Overrelease It within Exosomes, Effects Suppressed by Calcilytic NPS 2143-Further Implications for Alzheimer's TherapyUCH-L1 Inhibition Decreases the Microtubule-Binding Function of Tau Protein.Neurobiology of axonal transport defects in motor neuron diseases: Opportunities for translational research?Stable mutated tau441 transfected SH-SY5Y cells as screening tool for Alzheimer's disease drug candidates.Genetic variant of AKT1 and AKTIP associated with late-onset depression in a Brazilian population.Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.Changes in insulin-signaling transduction pathway underlie learning/memory deficits in an Alzheimer's disease rat model.Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration.
P2860
Q24338188-FC773C8E-559D-48D7-BBBA-11899193A97BQ26858788-1DDD8A3E-9538-4C6B-8573-59DD5A5C4C0CQ27331743-883EB2DA-5531-4DF8-86DE-5F052B691684Q33603862-B88D0979-B1F3-46DC-983C-C159AB22F944Q33736687-61BBB97E-8F0A-4DA2-BEA3-B87285B517BEQ35316005-95010AD3-BA92-4C24-9E27-4BEACA73D837Q35577571-8AD47986-7F4F-4DF4-9756-26A8D0124EC7Q36031159-81B4139A-750E-492E-8CAE-5CE182552071Q36052564-481974CD-C98E-4AB3-B041-D66663208D75Q36873750-118AEFB8-1D48-4F4B-B2C3-48788A41992BQ36898190-68F03140-1422-4A8D-B799-CB5544D0010AQ37040466-677E504F-8366-40DA-89D6-A0FF7702F432Q37071544-1C75BF75-1A63-4F62-B489-D3F441906C5EQ37384934-B5A66AB3-47A4-4405-BCE0-1FE5593F4C5EQ37405573-68F3A6D2-ADCA-413A-9734-0679704087A9Q37969262-D6972DC3-E954-46ED-902F-48EE9A8DB952Q38041425-B922FB95-B861-4863-909B-0BD3FA1354DBQ38204720-2A85412C-7C72-4CB8-AD3F-A0BF0FEBFF45Q38636753-5D8D90AC-C1FC-4619-A083-6D1C0C70F1CBQ38803172-06F2B29A-F7E4-4535-82B4-DD22CE50F73EQ38829786-9C43C9F7-371F-4943-A832-CE7F8854890EQ39149919-BBBD24C6-4A78-4F1B-8634-C21BCFE6D06FQ39393192-7B81FC42-04DF-4A9C-BC32-3ADDDD973CC3Q42270749-8A532810-0AF6-4F57-8F1C-CF2917F4F72AQ42281747-83DF93D7-4832-4912-88C6-F375A455E99FQ48552944-15FDACBD-CEA8-4E0B-8826-AA1FE97B468FQ52344625-21D0E928-D9E0-46D8-835B-BF84BE80079E
P2860
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation
@en
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation.
@nl
type
label
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation
@en
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation.
@nl
prefLabel
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation
@en
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation.
@nl
P2860
P356
P1476
Functional implications of glycogen synthase kinase-3-mediated tau phosphorylation
@en
P2860
P304
P356
10.4061/2011/352805
P577
2011-07-11T00:00:00Z